About US
Contact us
-
Pfizer recalls all Chantix lots nationwide over concerns of cancer-causing impurityPfizer's headache with its popular smoking cessation drug Chantix is escalating. After the drugmaker halted global distribution this summer and then recalled more than a dozen lots in the U.S., the c2021/9/15
-
Biogen's Alzheimer's drug Aduhelm slowly gaining steam among prescribing neurologists, study findsA week ago, Biogen CEO Michel Vounatsos sent the company's shares into a nosedive after disclosing its launch ofAlzheimer’s disease med Aduhelm was slower than expected. But according to one new anal2021/9/15
-
On a dealmaking roll, Sanofi lays out $1.9B for Kadmon and its newly launched transplant drugSanofi has yet to wrap up its $3.2 billion acquisition of mRNA specialist Translate Bio, but the French pharma is already reaching out to its wallet. This time, it’s making a play in general medicine2021/9/9
-
Another discount does the trick: Johnson & Johnson wins NICE backing for prostate cancer drug ErleadaA deeper discount was just the ticket for Johnson & Johnson as it hassecuredreimbursement in England for its prostate cancer drug Erleada. Less than four months ago, the National Institute of Hea2021/9/9
-
Amid vaccine hoarding criticism, Biden admin plots $2.7 billion manufacturing pushIt didn’t take long for the Biden administration to answer criticism that the United States wasn’t doing enough to ease the world’s COVID-19 vaccination shortfall. On Thursday, White House COVID resp2021/9/7
-
Lilly's COVID-19 antibody combo cleared for nationwide use as feds say it can tackle the dominant delta variantThat didn't take long. Only a few days after Eli Lilly's COVID-19 antibody combo of bamlanivimab and etesevimab made its return to more than 20 states, federal officials are resuming distribution nat2021/9/7
-
'A bitter result': Judge approves Purdue's $4.5B opioid settlement that protects Sackler family from future lawsuitsIn U.S. bankruptcy court on Wednesday, Judge Robert Drain spelled out the word that summed up his approval of a $4.5 billion settlement that protects owners of Purdue Pharma from future opioid litiga2021/9/3
-
Biogen's Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprisesWhile the chatter surrounding Biogen’s controversial Alzheimer's med Aduhelm has largely been centered on a pivotal Medicare reimbursement decision as of late, analysts are pointing to one new study2021/9/3
-
Biotech co-founders admit to stealing trade secrets from Roche's Genentech, face possible prison termsAfter two former staffers at Roche’s Genentech pleaded guilty to stealing biologics trade secrets, their co-conspirators didn’t put up much of a fight before admitting to their roles in the scheme. T2021/8/31
-
ESC 2021: Bayer's Kerendia touts outcomes data as it looks to complement J&J, AZ drugsWhen Bayer unveiled early-stage results from afinerenone trial atthe European Society of Cardiology Congress in 2014,the company declared it was going all in on the kidney disease drug. L2021/8/31